The present invention relates to an immunogenic product comprising TNFα coupled with KLH, wherein the TNFα is strongly inactivated, which means that the product shows less than 30% of cytolytic activity and/or an inactivation factor of more than 15000, in the conditions of TEST A; an emulsion and a vaccine comprising thereof and methods for preparing said immunogenic product.